Follow The Filings

IMUX Immunic

Immunic earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —

SEC filings

Recent issuer filings from EDGAR, 21 shown.

Filed Form Detail Links
8-K 5.02,9.01
8-K 7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
10-Q
8-K 2.02,5.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G —
SCHEDULE 13G/A —
8-K 7.01,9.01
8-K 5.02
8-K 5.02,5.07,9.01
DEF 14A Period Jun 29, 2026
8-K 7.01,9.01
8-K 5.02,7.01,9.01
8-K 5.02,7.01,9.01
SCHEDULE 13G/A —
SCHEDULE 13G/A —
8-K 2.02,9.01

Insider forms

Forms 3, 4 and 5 from EDGAR, 3 rows shown

Filed Form Detail Links
4 Period Sep 16, 2026 (2 forms)
4 Period Aug 6, 2026
4 Period Jul 5, 2026 (2 forms)

14 more insider forms

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.